134 related articles for article (PubMed ID: 20977423)
1. Role of glucocorticoids in breast cancer.
Vaidya JS; Baldassarre G; Thorat MA; Massarut S
Curr Pharm Des; 2010; 16(32):3593-600. PubMed ID: 20977423
[TBL] [Abstract][Full Text] [Related]
2. Possible roles for glucocorticoid signalling in breast cancer.
McNamara KM; Kannai A; Sasano H
Mol Cell Endocrinol; 2018 May; 466():38-50. PubMed ID: 28687451
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid resistance of migration and gene expression in a daughter MDA-MB-231 breast tumour cell line selected for high metastatic potential.
Fietz ER; Keenan CR; López-Campos G; Tu Y; Johnstone CN; Harris T; Stewart AG
Sci Rep; 2017 Mar; 7():43774. PubMed ID: 28262792
[TBL] [Abstract][Full Text] [Related]
4. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
Sládek NE; Kollander R; Sreerama L; Kiang DT
Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic agents targeting the glucocorticoid receptor for inflammation and cancer.
Sommer P; Ray DW
Curr Opin Investig Drugs; 2008 Oct; 9(10):1070-7. PubMed ID: 18821468
[TBL] [Abstract][Full Text] [Related]
6. Circadian and ultradian glucocorticoid rhythmicity: Implications for the effects of glucocorticoids on neural stem cells and adult hippocampal neurogenesis.
Fitzsimons CP; Herbert J; Schouten M; Meijer OC; Lucassen PJ; Lightman S
Front Neuroendocrinol; 2016 Apr; 41():44-58. PubMed ID: 27234350
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
8. Steroid hormones in 2013: Glucocorticoids: timing, binding and environment.
Lightman SL; George CL
Nat Rev Endocrinol; 2014 Feb; 10(2):71-2. PubMed ID: 24366119
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer.
Buxant F; Engohan-Aloghe C; Noël JC
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):254-7. PubMed ID: 19875955
[TBL] [Abstract][Full Text] [Related]
10. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids and chronic inflammation.
Straub RH; Cutolo M
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii6-ii14. PubMed ID: 27856655
[TBL] [Abstract][Full Text] [Related]
12. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer.
Mitre-Aguilar IB; Cabrera-Quintero AJ; Zentella-Dehesa A
Int J Clin Exp Pathol; 2015; 8(1):1-10. PubMed ID: 25755688
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucocorticoid use on survival in patients with stage I-III breast cancer.
Lin CH; Chuang PY; You SL; Chiang CJ; Huang CS; Wang MY; Chao M; Lu YS; Cheng AL; Tang CH
Breast Cancer Res Treat; 2018 Aug; 171(1):225-234. PubMed ID: 29761323
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid action and the development of selective glucocorticoid receptor ligands.
Cole TJ
Biotechnol Annu Rev; 2006; 12():269-300. PubMed ID: 17045197
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids and circadian clock control of cell proliferation: at the interface between three dynamic systems.
Dickmeis T; Foulkes NS
Mol Cell Endocrinol; 2011 Jan; 331(1):11-22. PubMed ID: 20833224
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine regulation of autoimmune/inflammatory disease.
Sternberg EM
J Endocrinol; 2001 Jun; 169(3):429-35. PubMed ID: 11375112
[TBL] [Abstract][Full Text] [Related]
17. Weak circadian rhythm increases neutropenia risk among breast cancer patients undergoing adjuvant chemotherapy.
Li W; Kwok CC; Chan DC; Wang F; Tse LA
Breast Cancer Res Treat; 2018 Apr; 168(2):483-493. PubMed ID: 29230661
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism.
De Martino MU; Alesci S; Chrousos GP; Kino T
Ann N Y Acad Sci; 2004 Jun; 1024():72-85. PubMed ID: 15265774
[TBL] [Abstract][Full Text] [Related]
19. Adrenal clocks and the role of adrenal hormones in the regulation of circadian physiology.
Leliavski A; Dumbell R; Ott V; Oster H
J Biol Rhythms; 2015 Feb; 30(1):20-34. PubMed ID: 25367898
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids.
Sapi E; Flick MB; Gilmore-Hebert M; Rodov S; Kacinski BM
Oncogene; 1995 Feb; 10(3):529-42. PubMed ID: 7845678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
